Pennsylvania

PharmaForce International: Research captures the best COVID-19 approach of US pharmaceutical companies | Around the Web-Pennsylvania

Reading, Pennsylvania, March 23, 2021 / PRNewswire / -PharmaForce International (PFI) has produced strategically relevant and timely reports to help understand the operational challenges of the pharmaceutical and biotechnology industry during a pandemic.Purpose of US COVID-19 Best Practice ReportCompleted in January this year, it shares insights on how companies are adapting to unprecedented situations.

PFI analysts conducted more than 150 interviews and surveys in eight months (March 2020 To December 2020) Across multiple pharmaceutical and biotechnology companies United States of America.. Interviewees include sales representatives, district / regional managers, medical science liaisons, and field market access personnel.

The COVID-19 pandemic has a significant impact on day-to-day activities at both industry and HCP levels. Pharmaceutical and biotechnology companies need to continually monitor the situation and coordinate field personnel approaches and strategies while adhering to regional, state, and national guidelines. PFI has observed different approaches across all functional areas facing customers, including sales, marketing, healthcare and market access. Not only the amount of customer interaction, but also the quality and nature of those particular engagements.

While working during the pandemic, each field-based role presents its own individual challenges. Sales reps have significantly increased virtual interactions with HCP rather than face-to-face interactions. However, this survey found that about 30% to 40% of HCPs do not meet sales reps directly or virtually. Since then, sales reps have made an average of about 1-2 HCP calls per day. March 2020..

Personnel assigned in the field medical role are less resistant to interaction from the HCP than personnel assigned in the field sales role. However, many on-site medical interviewers showed that the frequency and duration of KOL engagement was affected, noting that prior to COVID-19, KOL interactions lasted longer than in virtual environments. ..

Contact us for more information on the above report Joyce Wedemeyer so Joyce.Wedemeyer@pharmaforceintl.com Or by phone 610-370-2906.

Pharmaforce International (PFI) is a competitor information company with over 20 years of experience in the pharmaceutical and biotechnology industries. PFI has become a market leader in commercial benchmarks and competitor information.

To download multimedia, view the original content.http://www./news-releases/pharmaforce-international-research-captures-united-states-pharma-companies-best-covid-19-approaches-301254078.html

Source PharmaForce International

PharmaForce International: Research captures the best COVID-19 approach of US pharmaceutical companies | Around the Web-Pennsylvania

Source link PharmaForce International: Research captures the best COVID-19 approach of US pharmaceutical companies | Around the Web-Pennsylvania

Related Articles

Back to top button